Clinical Trials Logo

Diastolic Dysfunction clinical trials

View clinical trials related to Diastolic Dysfunction.

Filter by:

NCT ID: NCT05379608 Recruiting - Hypertension Clinical Trials

Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.

Start date: December 10, 2021
Phase: N/A
Study type: Interventional

Aim of this prospective, interventional, single-center, randomized study is to evaluate the efficacy and safety of intermittent hypoxic-hyperoxic training (IHHT) as a rehabilitation method in patients with cardiovascular pathology in the early period after coronavirus infection. The study will include 60 patients with cardiovascular pathology who underwent confirmed by laboratory tests COVID-19 infection 1-3 months ago with the degree of lung lesion CT3, CT4, who were admitted to the University Clinical Hospital No. 4 of I.M. Sechenov First Moscow State Medical University. The patients will be divided into 2 groups (intervention and control groups). Intervention group will inhale hypoxic gas mixtures (10-12% O2) followed by exposure to a hyperoxic gas mixture with 30-35% O2 5 times a week for 3 weeks, while control group will undergo a simulated IHHT. All the patients will undergo identical laboratory and instrumental testing before IHHT, after the last IHHT procedure, in a month after the last IHHT procedure and in 6 months. Estimated result of the study is to confirm or refute the hypothesis of the study that a three-week course of IHHT in patients with cardiovascular pathology in the early period after coronavirus infection can improve exercise tolerance, as well as the quality of life and psychoemotional status, and affect the dynamics of laboratory and instrumental parameters.

NCT ID: NCT04584203 Recruiting - Critical Illness Clinical Trials

Diastolic dYsfunctioN AssessMent in critICally Ill Patients

DYNAMIC
Start date: June 1, 2021
Phase:
Study type: Observational

The role of the left ventricular diastolic function (LVDD) in the weaning failure from mechanical ventilation in unclear. Specifically, is unclear whether the outcome of the weaning process could be affected by a pre-existing LVDD (before ICU admission), or by the worsening of a chronic pattern, or by a de-novo LVDD presentation.

NCT ID: NCT04558450 Recruiting - Covid19 Clinical Trials

Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)

CARTESIAN
Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.

NCT ID: NCT04149990 Recruiting - Clinical trials for Myocardial Infarction

Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

ARNiAMI
Start date: October 12, 2018
Phase: Phase 2
Study type: Interventional

This study examines the effect of Entresto on central hemodynamic parameters during exercise in patients with diastolic dysfunction following acute myocardial infarction. Half of the patients will receive Entresto and the other half will receive placebo.

NCT ID: NCT04117009 Recruiting - Clinical trials for Diastolic Dysfunction

Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction

Start date: November 1, 2019
Phase: Phase 4
Study type: Interventional

In this study ASA 1, 2 individuals with grade 1 or 2 diastolic dysfunction will be recruited to assess the effects of Remifentanil infusion on left ventricular function evaluated with transthoracic echocardiagraphy.

NCT ID: NCT04025996 Recruiting - Clinical trials for Diastolic Dysfunction

REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus

Start date: February 20, 2018
Phase:
Study type: Observational

Retinopathy may be associated with diastolic dysfunction and/or coronary flow reserve in the heart, and albuminuria in diabetic patients. The objective of this study is to examine the cross-sectional relationships of retinopathy with indices of left ventricular diastolic function, coronary flow reserve and urinary albumin excretion, among diabetic patients.

NCT ID: NCT03972644 Recruiting - Clinical trials for Aortic Valve Stenosis

Danish National Randomized Study on Early Aortic Valve Replacement in Patients With Asymptomatic Severe Aortic Stenosis

DANAVR
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the impact of early surgery in patients with asymptomatic severe aortic valve stenosis with signs of subclinical LV dysfunction despite preserved LVEF, with a watchfull waiting approach.

NCT ID: NCT03744975 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

Start date: May 1, 2018
Phase: Phase 2
Study type: Interventional

This study will advance the investigator's knowledge of the integrated cardiorenal and humoral physiology in type 2 diabetic patients with and without pre-clinical diastolic dysfunction, and test a novel therapeutic strategy which may prevent a progression to symptomatic Stage C heart failure

NCT ID: NCT03210012 Recruiting - Clinical trials for Endothelial Dysfunction

Bubbles, Stress, Diastole

Start date: June 11, 2017
Phase: N/A
Study type: Observational

This is a monocentric pilot study to assess the safety profile of a 30-meter deep underwater diving using 3 different type of gas mixtures: AIR (21% O2 and 79% N2), NITROX 32 (32% O2 And 68% N2) and TRIMIX (21% O2, 44% N2 and 35% He).

NCT ID: NCT03198611 Recruiting - Septic Shock Clinical Trials

Reversibility of Diastolic Disfunction in Septic Shock

REPRISS
Start date: March 1, 2018
Phase: N/A
Study type: Observational

Objectives: To study the prognostic value of the evolution of diastolic function according to fluid balance in patients admitted to the ICU with a diagnosis of septic shock, in terms of mortality (ICU and hospital) and mortality at 90 days. 2.4. Secondary objectives: A) Incidence and reversibility of myocardial dysfunction (left ventricular systolic and diastolic) in septic shock. B) Incidence and reversibility of diastolic dysfunction according to the echocardiographic criterion used. C) Incidence and reversibility of right ventricular systolic dysfunction.